Medical Properties Trust (NYSE:MPW) Upgraded by Zacks Research to "Hold" Rating

Key Points

• Zacks Research has upgraded Medical Properties Trust (NYSE:MPW) from a "strong sell" to a "hold" rating, indicating a shift in analyst sentiment regarding the company's stock.
• Medical Properties Trust's quarterly earnings report revealed a loss, with earnings per share (EPS) of $0.14, falling short of the expected $0.15 EPS, and a year-over-year revenue decline of 9.8%.
• Despite mixed ratings from analysts, the current average target price for Medical Properties Trust is $5.67, with two analysts rating it as a "buy" and five as a "hold."

Medical Properties Trust (NYSE:MPW - Get Free Report) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating in a note issued to investors on Wednesday, August 20th,Zacks.com reports.

MPW has been the topic of a number of other reports. Royal Bank Of Canada cut their price target on shares of Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating on the stock in a report on Monday, June 30th. Wall Street Zen downgraded shares of Medical Properties Trust from a "hold" rating to a "sell" rating in a report on Saturday, July 5th. Two research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $5.58.

Medical Properties Trust Stock Performance

Shares of MPW stock traded up $0.07 during trading hours on Wednesday, reaching $4.39. The company had a trading volume of 2,938,080 shares, compared to its average volume of 10,407,269. The business has a fifty day moving average price of $4.24 and a 200-day moving average price of $4.88. Medical Properties Trust has a one year low of $3.51 and a one year high of $6.55. The firm has a market cap of $2.64 billion, a PE ratio of -1.83 and a beta of 1.28. The company has a debt-to-equity ratio of 2.00, a quick ratio of 2.76 and a current ratio of 2.76.

Medical Properties Trust (NYSE:MPW - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The company had revenue of $240.36 million during the quarter, compared to the consensus estimate of $231.90 million. Medical Properties Trust had a negative return on equity of 28.80% and a negative net margin of 155.20%.The business's revenue was down 9.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.23 earnings per share. Sell-side analysts predict that Medical Properties Trust will post 0.78 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. grew its holdings in Medical Properties Trust by 13.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 10,020,568 shares of the real estate investment trust's stock worth $60,424,000 after acquiring an additional 1,182,028 shares during the period. Allianz Asset Management GmbH increased its holdings in shares of Medical Properties Trust by 43.2% during the 1st quarter. Allianz Asset Management GmbH now owns 7,134,629 shares of the real estate investment trust's stock valued at $43,022,000 after acquiring an additional 2,152,861 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Medical Properties Trust by 1.5% during the 1st quarter. Northern Trust Corp now owns 6,404,674 shares of the real estate investment trust's stock valued at $38,620,000 after acquiring an additional 95,525 shares during the last quarter. Wilsey Asset Management Inc. grew its holdings in Medical Properties Trust by 6.1% in the 2nd quarter. Wilsey Asset Management Inc. now owns 4,927,568 shares of the real estate investment trust's stock valued at $21,238,000 after buying an additional 281,591 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Medical Properties Trust by 11.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,086,848 shares of the real estate investment trust's stock worth $24,644,000 after purchasing an additional 410,374 shares in the last quarter. Institutional investors and hedge funds own 71.79% of the company's stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.